US Patent Issued to UNIVERSITA DEGLI STUDI DI PADOVA on March 4 for "Extracellular vesicles isolated from genetically modified cells over-expressing SERPINB3 for use in medicine" (Italian Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,667, issued on March 4, was assigned to UNIVERSITA DEGLI STUDI DI PADOVA (Padua, Italy).

"Extracellular vesicles isolated from genetically modified cells over-expressing SERPINB3 for use in medicine" was invented by Patrizia Pontisso (Padua, Italy), Maurizio Muraca (Padua, Italy), Alessandra Biasiolo (Selvazzano Dentro, Italy), Santina Quarta (Villaguattera di Rubano, Italy), Mariagrazia Ruvoletto (Vigonovo, Italy) and Gianmarco Villano (Padua, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns the therapeutic use of extracellular vesicles isolated from a genetically modified cell line over-expressing SerpinB3. In pa...